Anemia is a common, treatable condition in patients with aneurysmal subarachnoid
hemorrhage (SAH) and has been associated with poor outcome. As there are still no …

After years of research on treatment of aneurysmal subarachnoid hemorrhage (aSAH),
including randomized clinical trials, few treatments have been shown to be efficacious …

The pathophysiology of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid
hemorrhage (aSAH) is incompletely understood. Intrathecal activation of inflammatory …

Objective This study aims to compare the safety and efficacy of stent-assisted coiling (SAC)
with those of coiling alone (CA) for the treatment of ruptured tiny intracranial aneurysms …

Background and purpose The severity of early brain edema (EBE) after aneurysm rupture
was reported to be strongly associated with the risk of poor outcome after aneurysmal …

Stent-assisted coiling (SAC) for ruptured intracranial aneurysms (RIAs) remains
controversial due to an inherent risk of potential thromboembolic and hemorrhagic …

BACKGROUND Low-profiled visualized intraluminal support (LVIS) is suggested as a
promising stent for complex intracranial aneurysms. However, the safety and efficacy of LVIS …

BACKGROUND: Although Neuroform Atlas stent is commonly used in stent-assisted coiling
(SAC) to treat ruptured intracranial aneurysms (RIA), its safety and efficacy remain …

Objective To analyze the complications and long-term follow-up results of endovascular
treatment for ruptured intracranial posterior circulation aneurysms and identify outcome …

Background Symptomatic epilepsy is a common complication of aneurysmal subarachnoid
hemorrhage (aSAH) associated with poor outcome. We sought to analyze the risk factors …